-
Lau, LMS, Mayoh, C, Xie, J, Barahona, P, MacKenzie, KL, Wong, M, Kamili, A, Tsoli, M, Failes, TW, Kumar, A, et al.
In vitro and in vivo drug screens of tumor cells identify novel therapies for highârisk child cancer.
EMBO Molecular Medicine
14(4)
:
e14608
2022
view publication
-
Hu, W, Zhao, W, Kumar, A, Singh, GJ, Qi, S, Casan, J, Shembery, C, Fong, D, Zerbato, JM, Symons, J, et al.
De novo design of CRISPR-Cas13b enables efficient silencing of SARS-CoV-2 variants and tumour pathogenic RNAs with near single-base precision.
Pathology
54:
s15 -s16
2022
view publication
-
Subhash, VV, Huang, L, Kamili, A, Wong, M, Chen, D, Venn, NC, Atkinson, C, Mayoh, C, Venkat, P, Tyrrell, V, et al.
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
British Journal of Cancer
126(3)
:
482 -491
2022
view publication
-
Fordham, AM, Ekert, PG, Fleuren, EDG.
Precision medicine and phosphoproteomics for the identification of novel targeted therapeutic avenues in sarcomas.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
1876(2)
:
188613
2021
view publication
-
Manoharan, N, Ajuyah, P, Senapati, A, Wong, M, Mullins, A, Rodriguez, M, Doyle, H, McCowage, G, Lau, LMS, Ekert, PG, et al.
Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic analysis.
Acta Neuropathologica Communications
9(1)
:
147
2021
view publication